These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 16236914)
1. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Herder GJ; van Tinteren H; Golding RP; Kostense PJ; Comans EF; Smit EF; Hoekstra OS Chest; 2005 Oct; 128(4):2490-6. PubMed ID: 16236914 [TBL] [Abstract][Full Text] [Related]
2. Risk of malignancy in pulmonary nodules: A validation study of four prediction models. Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782 [TBL] [Abstract][Full Text] [Related]
3. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings. Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030 [TBL] [Abstract][Full Text] [Related]
4. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5. Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611 [TBL] [Abstract][Full Text] [Related]
5. The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules. Herder GJ; Golding RP; Hoekstra OS; Comans EF; Teule GJ; Postmus PE; Smit EF Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1231-6. PubMed ID: 15175835 [TBL] [Abstract][Full Text] [Related]
6. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan. Dewan NA; Shehan CJ; Reeb SD; Gobar LS; Scott WJ; Ryschon K Chest; 1997 Aug; 112(2):416-22. PubMed ID: 9266877 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930 [TBL] [Abstract][Full Text] [Related]
8. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT. Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules. Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082 [TBL] [Abstract][Full Text] [Related]
10. Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5. Chen CJ; Lee BF; Yao WJ; Cheng L; Wu PS; Chu CL; Chiu NT AJR Am J Roentgenol; 2008 Aug; 191(2):475-9. PubMed ID: 18647920 [TBL] [Abstract][Full Text] [Related]
11. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Bryant AS; Cerfolio RJ Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527 [TBL] [Abstract][Full Text] [Related]
13. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. Matthies A; Hickeson M; Cuchiara A; Alavi A J Nucl Med; 2002 Jul; 43(7):871-5. PubMed ID: 12097455 [TBL] [Abstract][Full Text] [Related]
14. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. Gupta NC; Maloof J; Gunel E J Nucl Med; 1996 Jun; 37(6):943-8. PubMed ID: 8683316 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. Fletcher JW; Kymes SM; Gould M; Alazraki N; Coleman RE; Lowe VJ; Marn C; Segall G; Thet LA; Lee K; J Nucl Med; 2008 Feb; 49(2):179-85. PubMed ID: 18199626 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic Performance of (18)F-Fluorodeoxyglucose in 162 Small Pulmonary Nodules Incidentally Detected in Subjects Without a History of Malignancy. Calcagni ML; Taralli S; Cardillo G; Graziano P; Ialongo P; Mattoli MV; Di Franco D; Caldarella C; Carleo F; Indovina L; Giordano A Ann Thorac Surg; 2016 Apr; 101(4):1303-9. PubMed ID: 26822348 [TBL] [Abstract][Full Text] [Related]
17. Multicenter external validation of two malignancy risk prediction models in patients undergoing 18F-FDG-PET for solitary pulmonary nodule evaluation. Perandini S; Soardi GA; Larici AR; Del Ciello A; Rizzardi G; Solazzo A; Mancino L; Zeraj F; Bernhart M; Signorini M; Motton M; Montemezzi S Eur Radiol; 2017 May; 27(5):2042-2046. PubMed ID: 27631108 [TBL] [Abstract][Full Text] [Related]
18. Integrating PET and CT information to improve diagnostic accuracy for lung nodules: A semiautomatic computer-aided method. Nie Y; Li Q; Li F; Pu Y; Appelbaum D; Doi K J Nucl Med; 2006 Jul; 47(7):1075-80. PubMed ID: 16818939 [TBL] [Abstract][Full Text] [Related]
19. Risk stratification in the investigation of pulmonary nodules in a high-risk cohort: positron emission tomography/computed tomography outperforms clinical risk prediction algorithms. Gibson G; Kumar AR; Steinke K; Bashirzadeh F; Roach R; Windsor M; Ware R; Fielding D Intern Med J; 2017 Dec; 47(12):1385-1392. PubMed ID: 28782248 [TBL] [Abstract][Full Text] [Related]
20. A model of malignant risk prediction for solitary pulmonary nodules on Yu M; Wang Z; Yang G; Cheng Y Thorac Cancer; 2020 May; 11(5):1211-1215. PubMed ID: 32162769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]